Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 79
- Proje 0
- Kitap 0
- Bildiri 0
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
7
Q2
30
Q3
40
Q4
17
WoS (JCR)
Q1
14
Q2
7
Q3
39
Q4
36
TR Index
42
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
2
Ort. yüzdelik
49.0%
Üst %1 payı
0.0%
Üst %10 payı
2.0%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Clonal Hematopoiesis in Newly Diagnosed Multiple Myeloma: Associations with Neutropenia, Supportive Care Burden and Survival YÖKSİS SJR Q2 JCR Q1 OpenAlex 66.8%
- 2026 Clinical Impact of Next‐Generation Sequencing–Detected Mutations on Thrombotic Events in Myeloproliferative Neoplasms YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 95.6%
- 2025 Arterial Thrombosis in Patients with Primary Immune Thrombocytopenia: A Nationwide Study YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 23.6%
- 2025 Evaluation of Venous Thromboembolism in Multiple Myeloma and Its Impact on Mortality YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 10.6%
- 2025 Gastrointestinal Manifestations of Mature B Cell Neoplasms: Single Center Experiences from the Collective Perspective of Hematology and Pathology YÖKSİS TR Index JCR Q4 OpenAlex 17.3%
- 2025 Analysis of Predictors of Progression-Free Survival and Early Response in Young Adult Classical Hodgkin Lymphoma YÖKSİS TR Index OpenAlex 32.2%
- 2024 Management of Primary Immune Thrombocytopenia – Turkish Modified Delphi-Based Consensus Statement for Special Considerations YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 56.2%
- 2024 Management of Adult Primary Immune Thrombocytopenia: Delphi-Based Consensus Recommendations YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 80.9%
- 2024 Real-world data on direct oral anticoagulants in BCR::ABL1-negative myeloproliferative neoplasms (MPNs): a multicenter retrospective study on behalf of scientific subcommittee on MPNs for Turkish society of hematology YÖKSİS SJR Q2 JCR Q2 OpenAlex 78.1%
- 2024 Myeloproliferative Neoplasm Symptom Assessment Total Symptom Score (MPN-SAF TSS) in Chronic Myeloproliferative Neoplasms, Related with Genetic Burden, and Thrombosis YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 10.3%
- 2024 The Role of Thalidomide and Its Analogs in the Treatment of Hereditary Hemorrhagic Telangiectasia: A Systematic Review YÖKSİS SJR Q1 JCR Q1 OpenAlex 89.4%
- 2024 The Impact of Focal Lesions on Overall and Progression-free Survival in Multiple Myeloma YÖKSİS SJR Q4 JCR Q4 OpenAlex 63.7%
- 2023 Incidence and predisposing factors of infection in patients treated with hypomethylating agents YÖKSİS SJR Q2 JCR Q3 OpenAlex 79.4%
- 2023 International Forum: The Turkish perspective on apheresis activity: The Turkish apheresis registry report YÖKSİS SJR Q3 JCR Q4 OpenAlex 43.1%
- 2022 Results of multicenter registry for patients with inherited factor VII deficiency in Turkey YÖKSİS SJR Q2 JCR Q4 OpenAlex 65.3%
- 2022 Could Antinuclear Antibody Positivity Be a Factor Affecting Treatment Response in Immune Thrombocytopenia Patients on Eltrombopag? YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 76.2%
- 2022 Castleman Disease: A Multicenter Case Series from Turkey YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 57.4%
- 2022 CD5 as a prognostic marker in patients with diffuse large B-cell lymphoma: a multicenter study YÖKSİS SJR Q3 JCR Q4 OpenAlex 60.4%
- 2022 The evaluation of risk factors leading to early deaths in patients with acute promyelocytic leukemia: a retrospective study YÖKSİS SJR Q1 JCR Q2 OpenAlex 53.2%
- 2022 Improving Care of Older Patients with Hemophilia During COVID-19 Pandemic, Reducing the Risk of Venous Thrombosis with Home Exercises YÖKSİS SJR Q2 JCR Q2 OpenAlex 2.9%